This invention is based in part on the elucidation of new structural conformations and functions of the sodium/potassium adenosine triphosphate synthase (Na/K ATPase), and especially elucidation of new binding sites and interactions. The present invention provides practical applications of several surprising structural and functional relationships between Na/K ATPase and compounds which interact with Na/K ATPase. Disclosure of these structures and relationships provides insight and practical solutions to chemically affecting not only the Na/K ATPase inte...
1. A method to affect cholesterol transport in a cell, comprising: administering to the cell a composition of matter comprising an amino acid compound of 17 residues comprising at least ten consecutive amino acid residues of a cholesterol recognition/interaction amino acid sequence and consensus pattern (CRAC) sequence having SEQ ID NO:2, or conservative substitutions of the at least ten consecutive amino acid residues of SEQ ID NO:2, wherein the compound is capable of binding cholesterol and affecting sodium/potassium adenosine triphosphate synthase (Na...
이 특허에 인용된 특허 (17)
- Larson, Drake. Catechin multimers as therapeutic drug delivery agents. USP2003056562864.
- Waller Todd A.. Cinnamoyl-C-glycoside chromone isolated from aloe barbadensis. USP1999105965540.
- Maroko Peter R. (1765 Garwood Dr. Cherry Hill NJ 08003). Compositions and method of treatment for improving circulatory performance. USP1992105153178.
- Singh, Chandra Ulagaraj; Nulu, Jagaveerabhadra Rao. Derivatives of sandalwood oil and santalols for treating cold sores and herpes. USP2010127858126.
- Nashimoto Kazuo,JPX ; Tashiro Yoshikazu,JPX. Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-clea. USP1999035888527.
- Shan,Jacqueline J.; Wu,Xi Chen; Pang,Peter K. T.; Ling,Lei. Hypericin andextract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics. USP2007037195783.
- Zhao,Jian; Zhou,Rui; Chen,Hu. Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof. USP2007017157493.
- Xie, Zijian; Shapiro, Joseph I.; Tian, Jiang. Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases. USP2012108283441.
- Ji, Joon Whan; Kang, Jae Ku; Kim, Young Hoon; Jung, Sung Hak; Cho, Hee Jae; Lee, Kwang Hyuk. Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract. USP2004046726935.
- Appelgren Curt H. (V Frlunda SEX) Bogentoft Conny B. (Kallered SEX). Pharmaceutically preparation comprising a cardiac glycoside in combination with a polymer. USP1981044261971.
- Smothers, Donald L.. Plant extraction method and compositions. USP2013098524286.
- Goodsall Christopher William,GBX ; Parry Andrew David,GBX ; Safford Richard,GBX ; Thiru Ambalavanar,GBX. Producing theaflavin. USP2000096113965.
- Fielding Christopher J. ; Fielding Phoebe E.. Regulation of the cell cycle by sterols. USP2001076261760.
- Addington, Otis Crandell; Zhang, Feng; Koleng, John J.. SCF extract containing cardiac glycoside. USP2013038394434.
- Burrell,Robert E.; Wright,John B.; Lam,Kan; Yin,Hua Qing; Naylor,Antony G.; Moxham,Peter H.; Gillis,Scott H.; Schechter,Paul. Solutions and aerosols of metal-containing compounds. USP2006077078060.
- Addington,Crandell. Supercritical carbon dioxide extract of pharmacologically active components from. USP2008077402325.
- Florkiewicz Robert Z.. Treatment of FGF-mediated conditions by administration of a cardiac glycoside or aglycone derivative thereof. USP2000066071885.